The Person-centered Evolution of Radiotherapy Services in Ontario Study
PERSON
1 other identifier
interventional
109
1 country
1
Brief Summary
This is a single center, prospective, investigator initiated, randomized controlled study of patients with breast cancer who will be receiving radiation therapy as per SOC. Patients will be randomized in either the person-centered model-of-care versus the standard model of care. Patients randomized to the person-centered model-of-care will have a 30 minute education session with a radiation therapist in addition to RT SOC procedures. Patients randomized to the standard model of care will be treated as per SOC. Questionnaires will be administered to both arms at baseline, and at the first and last day of treatment. In addition to the main study, patients will have the option to participate in a semi-structured one on one interview upon completion of their radiotherapy course.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Aug 2020
Longer than P75 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2020
CompletedFirst Posted
Study publicly available on registry
August 11, 2020
CompletedStudy Start
First participant enrolled
August 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
ExpectedMarch 5, 2026
March 1, 2026
1.6 years
July 29, 2020
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Anxiety Levels
Hospital Anxiety and Depression Scale (HADS) questionnaire
Up to 5 weeks.
Secondary Outcomes (5)
Patient-reported self-efficacy
Up to 5 weeks.
Patient-reported engagement level
Up to 5 weeks.
Patient-reported experience
Up to 5 weeks.
Patient-reported experience
Up to 5 weeks.
Patient-reported preparedness for radiation therapy
Up to 5 weeks.
Study Arms (2)
Person-Centered Model-of-Care
EXPERIMENTALPatients randomized to the person-centered model-of-care will have a 30 minute education session with a radiation therapist in addition to the standard of care, radiation therapy procedures.
Standard Model-of-Care
OTHERPatients randomized to the standard model of care will be treated as per standard of care.
Interventions
Quality of Life questionnaires will be administered to both arms at baseline, and at the first and last day of treatment.
Eligibility Criteria
You may qualify if:
- Patients 18 years or older
- Diagnosis of non-metastatic breast cancer
- Intended to receive radiation therapy to the breast/chest-wall and regional lymph nodes
- Ability to communicate in English without assistance of another person
- Ability to provide informed consent
You may not qualify if:
- Commenced any radiation therapy-specific procedures (e.g. education, CT-simulation, etc.)
- Received a previous course of radiation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2020
First Posted
August 11, 2020
Study Start
August 13, 2020
Primary Completion
March 24, 2022
Study Completion (Estimated)
August 1, 2027
Last Updated
March 5, 2026
Record last verified: 2026-03